Alembic receives EIR from USFDA for facility at Panelav

Alembic Pharmaceuticals Limited has received Establishment Inspection Report (EIR) today for the inspection carried out by the US Food and Drug Administration (USFDA) at our API - I & API - II Facility located at Panelav. The inspection was conducted from 26th May, 2025 to 31st May, 2025.

Tyche Industries completes GMP inspection by ANVISA

Tyche Industries Limited has announced the successful completion of GMP inspection by Brazilian Health Regulatory agency, ANVISA during 1 week of September, 2025 at our Kakinada facility.